Chronic drooling or sialorrhoea is evident in the pediatric population and is particularly prominent in those who suffer from neurological disorders such as cerebral palsy.
Download our poster titled, 'Development and Approval of a Palatable Glycopyrronium Bromide Liquid Formulation for Pediatrics' here.
Have a question about your pediatric drug program? Ask a member of our team about our capabilities for drug product clinical manufacturing, commercial manufacturing, or clinical testing to keep your pediatric drug program on-track.
Chief Scientific Officer
Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...
About AndrewExecutive Director, Pediatric Services
Nazim Kanji has over 25 years of experience in the pharmaceutical and consumer healthcare industries, where he has worked in produ...
About NazimVP, Integrated Development Services
Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...
About Asma